from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3138/pflA

LFCtreatmentdescriptionclass of inhibitor

-0.721

Amikacinug/mL Amikacintranslation

-0.636

Cap5-10ug/mL Capreomycintranslation

-0.906

Rox10-50 ug/mL Roxithromycintranslation

-0.401

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.647

Rif0.2-5ug/mL Rifampicintranscription

0.341

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.107

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.328

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.257

CPZ10-50 ug/mL Chlorpromazinerespiration

1.391

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.346

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.022

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.679

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.914

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.061

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.912

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.014

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.564

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.742

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.481

Nigericin50 uM Nigericinrespiration

0.479

TRC10-150 ug/mL Triclosanrespiration

1.296

TRZ10-25 ug/mL Thioridazinerespiration

-0.976

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.536

menadione6-10 ug/mL Menadionerespiration

0.282

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.011

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.102

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.792

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.985

NRP_1Non-replicating persistence stage 1dosRassociated

-0.006

Amp0.2mg/mL AmpicillincellWall

-0.090

Cephalexin20-100 ug/mL CephalexincellWall

0.212

Cerulenin0.32-5 ug/mL CerulenincellWall

0.132

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.331

EMB10-20 ug/mL EthambutolcellWall

0.062

Eta12-40 ug/mL EthionamidecellWall

-0.183

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.022

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.594

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.524

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.644

BZA0.12 mg/mL BenzamidearomaticAmides

-0.490

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.696

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.242

H2O24 mM hydrogen peroxideDNAdamaging

-0.125

Levo10 ug/mL LevofloxacinDNAdamaging

-0.180

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.269

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.049

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.301

UVUV-irradiationDNAdamaging

0.654

ARP41-4 ug/mL Antitubercular compound ARP4?

0.020

Antimycin12.5-50 ug/mL Antimycin A?

-0.900

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.660

PA_110-50 ug/mL Antitubercular compound PA-1?

0.306

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.354

PA8240.2-2 ug/mL PA-824?

1.251

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.006

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.581

Verapamil50 uM Verapamil?

-0.776

mercaptoethanol2 mM 2-Mercaptoethanol?

0.560

methoxatin10-20 ug/mL Methoxatin?